MedTrace Logo

The Automated Fluid Shunt (AFS)in Chronic Congestive Heart Failure

NCT00907673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2011-12-19

No results posted yet for this study

Summary

A 28-week, feasibility study to investigate the safety and efficiency of the Automatic Fluid Shunt in patients with chronic congestive heart failure, ascites and diuretic resistance.

Conditions

  • Congestive Heart Failure
  • Ascites

Interventions

DEVICE

Automatic Fluid Shunt System

Fully implantable peritoneal catheter, bladder catheter, and pump

Sponsors & Collaborators

  • NovaShunt AG

    lead INDUSTRY

Principal Investigators

  • Kristjan Karason, MD · Sahlgrenska University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00907673 on ClinicalTrials.gov